基本信息
文件名称:Tofacitinib-13C-Tasocitinib-sup-13-sup-C-生命科学试剂-MCE.pdf
文件大小:451.92 KB
总页数:1 页
更新时间:2025-05-21
总字数:约2.26千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Tofacitinib-13C

Cat.No.:HY-40354S3

Synonyms:Tasocitinib-13C;CP-690550-13C

分?式:C????CH??N?O

分?量:313.36

作?靶点:Isotope-LabeledCompounds

作?通路:Others

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Tofacitinib-13C(Tasocitinib-13C)是13C标记的Tofacitinib.Tofacitinib是JAK3/2/1抑制剂,IC50分别为

1,20和112nM。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthePharmacokineticsofPharmaceuticals.AnnPharmacother.2019;53(2):211-

216.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.